HIV infection, AIDS, and antiretroviral therapy (ART) have been associated with bone fragility fractures, although the prevalence and incidence are not well studied by researchers. In HIV and ART, osteopenia and osteoporosis are multifactorial, and health promotion or medical health maintenance should anticipate and prevent morbidity of bone fragility fractures.
Carr A, Miller J, Eisman JA, Cooper DA. Osteopenia in HIV-infected men: Association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS2001;15:703-709.
2.
Tebas P, Powderly WG, Claxton S, et al.Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS2000;14:F63-F67.
3.
Huang JS, Rietschel P, Hadigan CM, Rosenthal DI, Grinspoon S. Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy. AIDS2001;15:975-982.
4.
Hoy J, Hudson J, Law M, et al.Osteopenia in a randomized multicenter study of protease inhibitor (PI) substitution in patients with the lipodystrophy syndrome and well-controlled HIV viremia. 7th Conference on Retroviruses and Opportunistic Infections. January 30-February 2, 2000. San Francisco, CA, USA. (Abstract 208). Accessed August 14, 2004 from http://www.retroconfernce.org/2000/abstracts/208.htm
5.
Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS2003;17:1917-1923.
6.
Mondy K, Tebas P. Emerging bone problems in patients infected with human immunodeficiency virus. Clin Infect Dis2003;36(Suppl 2):S101-S105.
7.
Lawal A, Engelson ES, Wang J, Heymsfield SB, Kotler DP. Equivalent osteopenia in HIV-infected individuals studied before and during the era of highly active antiretroviral therapy. AIDS2001;15:278-280.
8.
McGowan I, Cheng A, Coleman S, Johnson A, Genant H. Assessment of bone mineral density (BMD) in HIV-infected antiretroviral-therapy naive patients. 8th Conference on Retroviruses and Opportunistic Infections. February 4-February 8, 2001. Chicago, IL, USA. (Abstract 628). Accessed August 14, 2004 from http://www.retroconference.org//2001/abstracts/abstracts/abstracts/628.htm
9.
Fessel WJ, Hurley LB. Is HIV sequestered in bone? Possible implications of virological and immunological findings in some HIV-infected patients with bone disease. AIDS2003;17:255-257.
10.
Stephens EA, Das R, Madge S, Barter J, Johnson MA. Symptomatic osteoporosis in two young HIV-positive African women. AIDS1999;13:2605-2606.
11.
Folefack DA, Arendt V, Schuman L. Fatigue fracture of the femoral neck in an HIV-positive female patient on antiretroviral therapy. Acta Orthop Belg2002;68:537-541. French.
12.
Rodriguez-Recio O, Junquera LM, Calvo N. Mandibular fracture after wire suspension reduction technique in patient with HIV. Br J Oral Maxillofac Surg2000;38:397.
13.
Guaraldi G, Ventura P, Albuzza M, Orlando G, Bedini A, Amorico G, Esposito R. Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy. AIDS2001; 15:137-138.
14.
Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome. J Clin Endocrinol Metab2001;86: 2020-2026.
15.
Paton NI, Macallan DC, Griffin GE, Pazianas M. Bone mineral density in patients with human immunodeficiency virus infection. Calcif Tissue Int1997;61:30-32.
16.
Anastos K, Hessol N. The association of bone mineral density and HIV infection and antiretroviral treatment in women. 11th Conference on Retroviruses and Opportunistic Infections. February 8-11, 2004. San Francisco, CA, USA. (Abstract 744). Accessed August 14, 2004 from http://www.retroconference.org/2004/cd/Abstract/744.htm
17.
Brown T, Timpone J, Ruppe M, et al.Bone loss associated with abnormalities in glucose metabolism in HIV patients on protease inhibitors (PIs). 9th Conference on Retroviruses and Opportunistic Infections. February 24-28, 2002. Seattle, WA, USA. (Poster 716-T). Accessed August 14, 2004 from http://www.retroconference.org/2002/Abstract/13246.htm
18.
Moore AL, Vashisht A, Sabin CA, et al.Reduced bone mineral density in HIV-positive individuals. AIDS2001;15:1731-1733.
19.
Nolan D, Upton R, McKinnon E, et al.Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS2001;15:1275-1280.
20.
Mondy K, Yarasheski K, Powderly WG, et al.Longitudinal evolution of bone mineral density and bone markers in HIV-infected individuals. Clin Infect Dis2003;36:482-490.
21.
Gold J, Pocock N, Li Y. Albion St Centre Osteoporosis and HIV Study Group. Bone mineral density abnormalities in patients with HIV infection. J Acquir Immune Defic Syndr2002;30:131-132.
22.
Wu F, Mason B, Horne A, Ames R, et al.Fractures between the ages of 20 and 50 years increase women’s risk of subsequent fractures. Arch Intern Med2002;162:33-36.
23.
Cooper C.The crippling consequences of fractures and their impact on quality of life. Am J Med1997;103:12S-17S.
24.
Johnell O.The socioeconomic burden of fractures: Today and in the 21st century. Am J Med1997;103:20S-25S.
25.
Browner WS, Seeley DG, Vogt TM, Cummings SR. Non-trauma mortality in elderly women with low bone mineral density. Lancet1991;338: 355-358.
26.
Cooper C, Atkinson EJ, Jacobsen SJ, O’Fallon WM, Melton LJ3rd. Population-based study of survival after osteoporotic fractures. Am J Epidemiol1993;137:1001-1005.
27.
Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR. Vertebral fractures and mortality in older women: A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med1999;159: 1215-1220.
